Methyl 2-(2-(3,4-dichlorophenyl)-3-(3-fluoro-4-methylbenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate

Catalog No. :
ACWOEZ217
CAS No. :
617697-96-8
Molecular Formula :
C24H17Cl2FN2O5S
Molecular Weight :
535.38

IUPAC Name:methyl 2-(2-(3,4-dichlorophenyl)-3-(3-fluoro-4-methylbenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate

Methyl 2-(2-(3,4-dichlorophenyl)-3-(3-fluoro-4-methylbenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(2-(3,4-dichlorophenyl)-3-(3-fluoro-4-methylbenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate
IUPAC Namemethyl 2-(2-(3,4-dichlorophenyl)-3-(3-fluoro-4-methylbenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate
Molecular FormulaC24H17Cl2FN2O5S
Molecular Weight535.38
SMILESCOC(=O)C1=C(C)N=C(N2C(=O)C(O)=C(C(=O)C3=CC=C(C)C(F)=C3)C2C2=CC=C(Cl)C(Cl)=C2)S1
InChI KeyIKVFFZMNHYIOOA-UHFFFAOYSA-N
SynonymMETHYL 2-[2-(3,4-DICHLOROPHENYL)-3-(3-FLUORO-4-METHYLBENZOYL)-4-HYDROXY-5-OXO-2,5-DIHYDRO-1H-PYRROL-1-YL]-4-METHYL-1,3-THIAZOLE-5-CARBOXYLATE;SALOR-INT L419354-1EA
CAS No.617697-96-8

Synthetic Route by SureRoute

1. ACWOEZ217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWOEZ217 route product structure diagram
    ACWOEZ217617697-96-8
Inquiry

2. ACWOEZ217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWOEZ217 route product structure diagram
    ACWOEZ217617697-96-8
Inquiry

Comments (0)